"Clinically predictive preclinical efficacy testing services at your disposal"


Jussi Halleen - CEO, Pharmatest Services

Pharmatest Services Ltd attends ASBMR Annual Meeting in Houston

Pharmatest Services Ltd attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) that will be held in Houston, TX, USA on September 12 – 15, 2014. Pharmatest has three scientific presentations in the meeting and welcomes everyone to visit our booth #220.

Pharmatest Services Ltd (Pharmatest) is a contract research organization that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. The ASBMR Annual Meeting is the leading scientific event in the field of bone research globally. 

This year Pharmatest attends ASBMR with three scientific presentations that demonstrate development of novel research models for osteoarthritis research. The models described in the presentations were developed in a project funded by the Eurostars programme, and they can be used for testing efficacy of customer compounds for osteoarthritis treatment.

Each poster handout will be available here after the start of the corresponding poster session:

- An in Vitro Chondrogenic Differentiation Model Using KS483 Mouse Mesenchymal Progenitor Cell Line

- Characterization of Monosodium Iodoacetate Induced Osteoarthritis in Rat Knee, Including Patellofemoral and Tibiofemoral Joints

- Intra-Articular Treatment with Recombinant Human Bone Morphogenetic Protein 7 (rhBMP-7) Attenuates the Development of Post-Traumatic Osteoarthritis in Rats

If you would like to schedule a meeting with our representatives during the ASBMR meeting, click here.